• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Dr. Brett Malbin Presentation

News
Video

Watch Dr. Malbin's presentation of Intravenous Prostaglandin E1 Infusion for Acute Central Retinal Artery Occlusion.

Dr. Malbin's PDF presentation can be found

here
Related Videos
Related Content
Oculis announces first patient first visit in Phase 2b RELIEF Trial of Topical Anti-TNFα licaminlimab in dry eye disease

Oculis announces first patient first visit in Phase 2b RELIEF Trial of Topical Anti-TNFα licaminlimab in dry eye disease

Article
Week in Review - November 26, 2023

Week in Review - November 26, 2023

Podcast
Study: Fish-like genetic program used to turn human Müller glia cells into neurons

Study: Fish-like genetic program used to turn human Müller glia cells into neurons

Article
Week in Review - November 12, 2023

Week in Review - November 12, 2023

Podcast
Atsena Therapeutics announces positive 12-month safety, efficacy Data from Phase I/II clinical trial of ATSN-101

Atsena Therapeutics announces positive 12-month safety, efficacy Data from Phase I/II clinical trial of ATSN-101

Article
Research unveils subtle ocular changes with anti-VEGF therapies

Research unveils subtle ocular changes with anti-VEGF therapies

Article
© 2023 MJH Life Sciences

All rights reserved.